AltheaDx Prospective, Randomized Controlled Clinical Trial Demonstrates Significant Improvements in the Treatment of Depression and Anxiety over Standard of Care
SAN DIEGO, Sept. 26, 2017 /PRNewswire/ — AltheaDx, Inc. (“AltheaDx” or the “Company”), a commercial stage molecular diagnostics company specializing in the field of personalized medicine, announced today that the results from its clinical trial have been accepted for publication… Read the rest